Swiss start rolling review of Moderna COVID-19 vaccine candidate

ZURICH (Reuters) – Swiss drugs regulator Swissmedic said on Friday it has begun a rolling review of a COVID-19 vaccine candidate from U.S.-based Moderna , which is currently analyzing data from a large-scale clinical trial in thousands of patients.

(Reporting by John Miller; Editing by Michael Shields)